Tauopathies

• Published in: Cellular and molecular life sciences : CMLS Vol. 64; no. 17; pp. 2219 - 2233
• Main Authors: Hernández, F, Avila, J
• Format: Journal Article
• Language: English
• Published: Switzerland Basel : Birkhäuser-Verlag 01.09.2007; Springer Nature B.V; Birkhäuser-Verlag
• Subjects: Alzheimer disease; Alzheimer Disease - metabolism; Alzheimer's disease; FTDP-17; Humans; Metabolism; Models, Biological; Multi-author Review; Mutation; Neurology; paired helical filaments; Pathology; Phosphorylation; Protein Processing, Post-Translational; Proteins; tau; tau Proteins - genetics; tau Proteins - metabolism; tau Proteins - physiology; Tauopathies; Tauopathies - metabolism
• ISSN: 1420-682X; 1420-9071
• DOI: 10.1007/s00018-007-7220-x

Tau is a microtubule-associated protein predominantly expressed in nerve cells that promote microtubule assembly and microtubule stabilization. Tau is a cytosolic protein mainly present in axons and involved in anterograde axonal transport. In several neurodegenerative diseases, as for example Alzheimer's disease, tau metabolism is altered. Thus, alterations in the amount of the tau protein, missense mutations, posttranscriptional modifications like phosphorylation, aberrant tau aggregation or a different expression of some of its isoforms could provoke pathological effects resulting in the appearance of neuronal disorders known as tauopathies. The purpose of this work is to review the possible mechanisms for tau alterations that could lead to the onset of tau pathology. First we will focus on tau turnover, then on tau phosphorylation and, finally, on tau aggregation.